doi: 10.3389/fnagi.2020.00209 Received 10 February 2020 Accepted 15 June 2020 Published 14 July 2020 Volume 12 - 2020 Edited by Rubem C
Immune-modulating effects of GLP-1 receptor agonists are reported in several preclinical cancer studies, which may reflect direct action on immune cells or result from improved metabolic function
The powder product is lyophilized within sterile 10mL vials and must be reconstituted prior to laboratory handling
An alpha subunit identical to those found in luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone
Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden
For researchers developing small-molecule inhibitors, nucleic acid therapeutics, uricosuric agents, or anti-inflammatory biologics, choosing the right animal model can directly influence the interpretability and translational value of preclinical data